Cargando…
Neuroprotective effects of osmotin in Parkinson’s disease-associated pathology via the AdipoR1/MAPK/AMPK/mTOR signaling pathways
BACKGROUND: Parkinson’s disease (PD) is the second most frequent age-related neurodegenerative disorder and is characterized by the loss of dopaminergic neurons. Both environmental and genetic aspects are involved in the pathogenesis of PD. Osmotin is a structural and functional homolog of adiponect...
Autores principales: | Park, Jun Sung, Choe, Kyonghwan, Lee, Hyeon Jin, Park, Tae Ju, Kim, Myeong Ok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422754/ https://www.ncbi.nlm.nih.gov/pubmed/37568205 http://dx.doi.org/10.1186/s12929-023-00961-z |
Ejemplares similares
-
AdipoR2 inhibits human glioblastoma cell growth through the AMPK/mTOR pathway
por: Jie, Chen, et al.
Publicado: (2021) -
Novel osmotin inhibits SREBP2 via the AdipoR1/AMPK/SIRT1 pathway to improve Alzheimer's disease neuropathological deficits
por: Shah, S A, et al.
Publicado: (2017) -
Resveratrol increases AdipoR1 and AdipoR2 expression in type 2 diabetic nephropathy
por: Park, Hoon Suk, et al.
Publicado: (2016) -
Erratum to: Resveratrol increases AdipoR1 and AdipoR2 expression in type 2 diabetic nephropathy
por: Park, Hoon Suk, et al.
Publicado: (2016) -
AdipoRon Engages Microglia to Antinociception through the AdipoR1/AMPK Pathway in SNI Mice
por: Fang, Qian, et al.
Publicado: (2023)